Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients

  • Mariantonia Logozzi,

    Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy

  • Angelo De Milito,

    Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy

  • Luana Lugini,

    Affiliation Unit of Molecular and Cellular Imaging, Istituto Superiore di Sanità, Rome, Italy

  • Martina Borghi,

    Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy

  • Luana Calabrò,

    Affiliation Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy

  • Massimo Spada,

    Affiliation Unit of Experimental Immunotherapy, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy

  • Maurizio Perdicchio,

    Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy

  • Maria Lucia Marino,

    Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy

  • Cristina Federici,

    Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy

  • Elisabetta Iessi,

    Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy

  • Daria Brambilla,

    Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy

  • Giulietta Venturi,

    Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy

  • Francesco Lozupone,

    Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy

  • Mario Santinami,

    Affiliation Unit of Melanoma and Sarcoma, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

  • Veronica Huber,

    Affiliation Unit of Immunotherapy of Human Tumours, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

  • Michele Maio,

    Affiliations Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy, Unit of Cancer Bioimmunotherapy, Department of Medical Oncology, Centro di Riferimento Oncologico IRCCS, Aviano, Italy

  • Licia Rivoltini,

    Affiliation Unit of Immunotherapy of Human Tumours, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy

  •  [ ... ],
  • Stefano Fais

    stefano.fais@iss.it

    Affiliation Unit of Antitumor Drugs, Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy

  • [ view all ]
  • [ view less ]

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.